Trials / Completed
CompletedNCT03741660
Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM
Konjac-Mannan (Glucomannan) Improves Glycemia and Other Associated Risk Factors for Coronary Heart Disease in Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Unity Health Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To examine whether Konjac-mannan fiber improves metabolic control measured by glycemia, lipidemia, and blood pressure in individuals with type-2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | konjac glucomannan | Konjac-mannan fiber-enriched biscuits (0.7 g/412KJ \[100kcal\] of glucommanan) |
| DIETARY_SUPPLEMENT | wheat bran | Wheat bran (hard red wheat bran) fiber enriched biscuits |
Timeline
- Start date
- 1991-01-01
- Primary completion
- 1992-06-01
- Completion
- 1998-06-01
- First posted
- 2018-11-15
- Last updated
- 2018-11-15
Source: ClinicalTrials.gov record NCT03741660. Inclusion in this directory is not an endorsement.